ImmunSkills SA develops allogenic cell‑based therapies for solid cancers, aiming to create a product using allogenic cells that can kill various cancer cells and modify the tumour microenvironment to reduce treatment resistance.
AI-generated
Comparisons
ImmunSkills SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank ImmunSkills SA by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.